Update shared on04 Sep 2025
Fair value Decreased 0.062%With both the discount rate and future P/E remaining essentially flat, the consensus analyst price target for Clean Science and Technology is unchanged at ₹1477.
What's in the News
- Promoters Ashok Boob and Krishnakumar Boob may sell a 24% stake in Clean Science and Technology for over INR 26,265 million via a block deal, representing 2.55 crore shares at a floor price of INR 1,030 per share (a 12.8% discount to the previous closing).
- JP Morgan India will act as brokers for the transaction, with the promoter group’s stake at 74.97% as of June 30.
- The board will meet to consider and approve Q1 FY26 unaudited standalone and consolidated financial results, as well as other matters.
Valuation Changes
Summary of Valuation Changes for Clean Science and Technology
- The Consensus Analyst Price Target remained effectively unchanged, at ₹1477.
- The Discount Rate for Clean Science and Technology remained effectively unchanged, moving only marginally from 13.45% to 13.44%.
- The Future P/E for Clean Science and Technology remained effectively unchanged, moving only marginally from 41.42x to 41.39x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.